PodcastsLife SciencesATTD: Advanced Technologies and Treatments for Diabetes

ATTD: Advanced Technologies and Treatments for Diabetes

ATTD on UNLOK
ATTD: Advanced Technologies and Treatments for Diabetes
Latest episode

70 episodes

  • ATTD: Advanced Technologies and Treatments for Diabetes

    Smart Tools & Technology for Better Insulin Outcomes

    02/06/2026 | 17 mins.
    In this episode, host Bob Gabbay and his guest, Professor Tadej Battelino, Co-Chair of ATTD, discuss the latest technological innovations in diabetes, including delivery innovations, connected devices, titration support.
    They discuss:
    The new technologies making the biggest difference in insulin therapy today

    The role of smart pens, connected devices, and apps

    Biggest clinical impact - including adherence, titration and outcomes

    Accessibility of these tools in real-world practice

    Advisor role of AI

    The promising future of technology in insulin therapy and a functional cure

    Professor Tadej Battelino is Co-Chair of ATTD and Chair of International Diabetes Federation Europe.
    Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!
    Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.
  • ATTD: Advanced Technologies and Treatments for Diabetes

    Fixed-Ratio Combinations (FRCs) in Practice

    19/05/2026 | 14 mins.
    In this episode, host Bob Gabbay and his guest, Dr George Grunberger, Chairman of the Grunberger Diabetes Institute, discuss best practice and guidance around basal insulin and GLP-1 combinations.
    They discuss:
    What exactly fixed-ratio combinations are and the problems they tackle

    Identifying patient candidates and timelines for starting FRCs

    Meaningful benefits of FRCs compared with basal insulin alone

    Concerns and limitations of FRCs

    How guideline recommendations currently position FRCs in diabetes management

    Dr George Grunberger, Chairman of the Grunberger Diabetes Institute in Michigan. George is also Clinical Professor of Internal Medicine at Wayne State University School of Medicine, and Professor of Internal Medicine at Oakland University William Beaumont School of Medicine.
    Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!
    Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.
  • ATTD: Advanced Technologies and Treatments for Diabetes

    Safe & Effective Insulin Titration Strategies

    05/05/2026 | 18 mins.
    In this episode, host Bob Gabbay and his guest, Dr William Polonsky discuss safe and effective titration strategies, and the importance of collaborating with your patient.
    They discuss:
    The importance of titration in successful insulin therapy

    Barriers to titration, including patient self-management

    How clinicians can collaborate with patients in their titration journey

    The importance of language used by clinicians

    Practical tips for simplifying titration in busy clinical settings

    Dr. Polonsky is President and Founder of the Behavioral Diabetes Institute, and Associate Clinical Professor in Psychiatry at the University of California.
    Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!
    Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.
  • ATTD: Advanced Technologies and Treatments for Diabetes

    Identifying Patients for Insulin Initiation in T2D

    21/04/2026 | 19 mins.
    In this episode, host Bob Gabbay and his guest, Dr Osama Hamdy, discuss how clinicians can identify patients for insulin initiation in Type 2 diabetes.
    They discuss:
    When clinicians should consider insulin for patients with T2D

    Addressing concerns of weight gain with insulin

    ADA/EASD recommendations

    Barriers to insulin therapy and Type 2 diabetes

    Advice on communication with patients

    Dr Osama Hamdy is Associate Professor of Medicine at Harvard Medical School, and Director of the Obesity Clinical Program at the Joslin Diabetes Center.
    Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!
    Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.
  • ATTD: Advanced Technologies and Treatments for Diabetes

    Principles of Basal Insulin Therapy in Type 2 Diabetes

    07/04/2026 | 18 mins.
    In our new series, Insulin in Practice, host Dr Bob Gabbay looks at the principles of Basal Insulin Therapy in Type 2 Diabetes; its physiological role, pharmacodynamics, and current guideline-based use.
    He is joined by Dr Giulio Romeo.
    They discuss:
    The role of basal insulin in normal physiology and why it matters in Type 2 diabetes

    Goals of basal insulin therapy

    What makes new basal insulins different

    Current guidelines and recommendations for basal insulin therapy

    Alternatives to basal insulin therapy

    Tips for safe and effective initiation and titration

    Dr Giulio Romeo is Associate Medical Director of the Adult Diabetes Section at Joslin Diabetes Center, and Assistant Professor of Medicine, Harvard Medical School.
    Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!
    Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.
More Life Sciences podcasts
About ATTD: Advanced Technologies and Treatments for Diabetes
ATTD is the leading forum for the latest in diabetes research, technology, and clinical innovation. This podcast offers two types of content for healthcare professionals: * ATTD Conference Catch-up: AI-generated episodes with key insights from expert presentations & research discussions. * Curated Series: Human-led conversations such as ATTD Tech Connect (sponsored by Medtronic), and previously Long-Acting Insulin Uncovered (supported by Eli Lilly and Company) and CGM in Focus (supported by Dexcom). Whether you're a specialist, researcher, or industry leader, hit subscribe.
Podcast website

Listen to ATTD: Advanced Technologies and Treatments for Diabetes, Project Medtech and many other podcasts from around the world with the radio.net app

Get the free radio.net app

  • Stations and podcasts to bookmark
  • Stream via Wi-Fi or Bluetooth
  • Supports Carplay & Android Auto
  • Many other app features